Biotechnology · Healthcare
General Counsel
Equibles does not estimate personal net worth.
Earlier roles on record: General Counsel at Vanda Pharmaceuticals Inc. (VNDA) until April 10, 2026. Vanda Pharmaceuticals Inc. reported in an 8-K filed April 2, 2026 that Timothy Williams resigned as Senior Vice President, General Counsel and Secretary, effective April 10, 2026. The proxy statement of Vanda Pharmaceuticals Inc. reports total compensation of $1,444,969 for Timothy Williams in fiscal 2025, including a base salary of $559,935. Disclosed compensation is on record for 8 fiscal years. Timothy Williams has spoken on 3 earnings calls across 1 company, most recently for Vanda Pharmaceuticals Inc. on May 3, 2023. The companies whose calls Timothy Williams spoke on are classified in the Healthcare sector.
“On March 29, 2026, Timothy Williams notified Vanda Pharmaceuticals Inc. (the "Company") of his resignation as the Company's Senior Vice President, General Counsel and Secretary, effective as of April 10, 2026, in order to pursue other endeavors.”
“I'll provide a brief recap of our ongoing litigation efforts, all of which are currently matters of public record, starting with our actions regarding HETLIOZ intellectual property and generic competition.”
“As you probably know, in December, the Delaware District Court found certain of our HETLIOZ patent claims invalid or not infringed by the generic defendants in our Vanda litigation.”
“As Mihales and Kevin both mentioned, we're continuing to address reimbursement delays and improper denials for HETLIOZ patients and we've made significant progress in the past quarter, particularly with state Medicaid programs.”
Start not stated–2026-04-10
Biotechnology · Healthcare
General Counsel
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Vanda Pharmaceuticals Inc. (VNDA) | Senior Vice President, General Counsel and Secretary | $559,935 | $1,444,969 |
| 2024 | Vanda Pharmaceuticals Inc. (VNDA) | Senior Vice President, General Counsel and Secretary | $541,000 | $1,453,114 |
| 2023 | Vanda Pharmaceuticals Inc. (VNDA) | Senior Vice President, General Counsel and Secretary | $520,000 | $1,399,802 |
| 2022 | Vanda Pharmaceuticals Inc. (VNDA) | Senior Vice President, General Counsel and Secretary | $466,400 | $1,504,866 |
| 2021 | Vanda Pharmaceuticals Inc. (VNDA) | Senior Vice President, General Counsel and Secretary | $440,000 | $2,032,128 |
| 2020 | Vanda Pharmaceuticals Inc. (VNDA) | Senior Vice President, General Counsel and Secretary | $400,000 | $1,379,061 |
| 2019 | Vanda Pharmaceuticals Inc. (VNDA) | Senior Vice President, General Counsel and Secretary | $379,315 | $2,022,854 |
| 2018 | Vanda Pharmaceuticals Inc. (VNDA) | Senior Vice President, General Counsel and Secretary | $144,886 | $2,002,856 |